May 12, 2011

MDCO new position (speculative)

The Medicines Company is one stock which we had followed for long time through its ups and downs. Recently MDCO hired John Kelly (formely VP controller at Wyeth - which got acquired by Pfizer in 2009). Soon after J Kelly retired from Pfizer-Wyeth.

Interestingly enough, recently (Apr 28, 2011) John Kelly has been appointed to the Board of Directors of the Medicines Company. Could this hint toward a possible takeover being in the works? Maybe/maybe not. but then, this is why its called a speculative position.

MDCO did report good results recently (Link) where it reported 64 c eps vs an analyst estimate of 40 c/eps.

Do your own due diligence. Good luck.

Disclosure: long MDCO since 16.15/share.

No comments:

Post a Comment

Your comments and opinions here!

Join the Discussion